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ABSTRACT
Genomic instability leads to mutations, cellular
dysfunction and aberrant phenotypes at the tissue
and organism levels. A number of mechanisms have
evolved to cope with endogenous or exogenous
stress to prevent chromosomal instability and
maintain cellular homeostasis. DNA helicases play
important roles in the DNA damage response. The
RecQ family of DNA helicases is of particular
interest since several human RecQ helicases are
defective in diseases associated with premature
aging and cancer. In this review, we will provide an
update on our understanding of the specific roles of
human RecQ helicases in the maintenance of
genomic stability through their catalytic activities
and protein interactions in various pathways of
cellular nucleic acid metabolism with an emphasis
on DNA replication and repair. We will also
discuss the clinical features of the premature
aging disorders associated with RecQ helicase
deficiencies and how they relate to the molecular
defects.
INTRODUCTION
DNA repair pathways
Cellular DNA is continuously being damaged by
exogenous and endogenous agents and chemicals, which
generate many types of lesions throughout the genome (1).
Many of the oxidative DNA modiﬁcations that accumu-
late in nucleic acids over time are thought to be caused
by endogenous reactive oxygen species (ROS), which are
produced as normal by-products of oxidative phosphor-
ylation in mitochondria as well as other metabolic
processes. It has been estimated that between 50000
and 100000 oxidative DNA lesions are generated per
mammalian cell per day. If DNA damage persists, it can
cause errors in DNA replication or transcription leading
to point mutations or chromosomal rearrangements, or
induce a stress response via various signaling pathways.
Cells have multiple DNA repair pathways that provide
distinct but overlapping capacity to remove and/or repair
many DNA lesions (2) (Figure 1). There are multiple
cellular responses to DNA damage and a number of
distinct DNA repair processes have been identiﬁed.
While they represent documented pathways, there is also
a great deal of overlap between them and between DNA
repair processes and signaling processes elicited by
DNA damage.
The four main DNA repair pathways are: base
excision repair (BER), which repairs oxidative DNA
base modiﬁcations such as 8-oxoguanine, alkylation base
damage and ssDNA breaks; nucleotide excision repair
(NER), which repairs bulky helix-distorting DNA lesions;
double strand break repair (DSBR), which repairs dsDNA
breaks; and mismatch repair (MMR), which repairs
single nucleotide mismatches and small insertion-deletion
mispairs. DNA repair subpathways have also been
characterized, including the global genome repair (GGR)
and transcription coupled repair (TCR) subpathways
of NER, long patch (LP-BER) and short patch BER
(SP-BER), and homologous recombination (HR) and
non-homologous endjoining (NHEJ), which are subpath-
ways of DSBR (Figure 1).
Emerging work has provided compelling evidence
for critical roles of DNA helicases in various aspects of
DNA repair in addition to their functions in processes
associated with DNA replication and recombination.
Importantly, RecQ helicases have essential roles in DNA
metabolism that directly have an impact on chromosomal
stability. Understanding the roles of DNA helicases in
the maintenance of genomic stability has become an
important challenge since aging, cancer and a number of
genetic diseases have been either directly linked or
associated with defects in human DNA helicases. Of
particular interest has been the role of RecQ helicases, the
topic of this review, in chromosomal stability maintenance
since our understanding of this family of proteins has
advanced signiﬁcantly over the last decade. Although we
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and genome stability, the precise basis for the molecular
and cellular phenotypes associated with mutations or
deﬁciencies in the human RecQ helicases has not been
fully realized.
RecQhelicase disorders: chromosomal instability,
cancer and aging
Mutations in human RecQ helicases result in rare diseases
of aging and cancer characterized by chromosomal
instability (Table 1). The most striking clinical feature of
Werner syndrome (WS) is the early onset of aging-related
diseases (3,4). WS patients have an elevated risk of
age-associated diseases such as cardiovascular disease,
diabetes mellitus (Type II) and osteoporosis. Unlike
normal individuals, WS patients are highly susceptible to
early onset of sarcomas and mesenchymal tumors. Bloom
syndrome (BS) is associated with an early incidence of
most types of cancers, including sarcoma (e.g. osteosarco-
mas). While the malignancies found in BS reﬂect what is
normally seen in the population, just at an early stage in
life, the malignancies found in WS are diﬀerent from the
spectrum in the normal population. WS patients have
particularly a high incidence of sarcomas, and this may
relate to the hyperoxidation found in WS associated with
the BER deﬁciency (5). The pro-oxidant state in WS (6)
and defects in oxidative DNA damage processing (to be
discussed) may contribute to the higher levels of oxidation
seen in tumors such as sarcomas that occur in this
syndrome. Individuals with WS are actually fertile
(albeit hypogonadal) (7), while males with BS are sterile
and BS females undergo premature menopause (8).
The incidence of clinical features in WS patients was
recently estimated using data from the WS registry (9).
Two clinical features, cataracts and voice hoarseness,
occur in 100% of WS cases. Interestingly, cataracts are
also common in other DNA repair-deﬁciency diseases,
suggesting that lens proteins could be more susceptible
to oxidation in patients with these diseases. Gene
expression microarray studies using mRNA from WS
primary ﬁbroblasts showed an expression pattern more
similar to normal ﬁbroblasts from old individuals than
to normal ﬁbroblasts from young individuals (10). Despite
the fact that WS and BS patients demonstrate early
onset of many features of normal aging, not all
characteristics of normal aging are accelerated in these
patients; thus, WS and BS are known as segmental
progerias. There is considerable interest in understanding
the pathogenesis of human progeroid syndromes such
as WS or Hutchinson-Gilford syndrome (11).
Much work has been done to characterize the
cellular phenotypes and genomic instability of WS and
BS (3,12–15). BS cells are characterized by higher levels of
sister chromatid exchange (SCE) than wild type cells, and
both BS and WS cells are characterized by higher
than normal levels of chromosomal aberrations and
hypersensitivity to various agents that induce DNA
damage or interfere with replication, including topoi-
somerase I inhibitors or DNA interstrand crosslinking
agents. BS and WS cells also progress more slowly
through S-phase than wild type cells, suggesting that cell
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Figure 1. DNA repair pathways responsible for the correction of endogenous or exogenously induced DNA damage.
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cells, even in the absence of cellular stress.
Individuals with mutations in RECQ4 are aﬄicted
with Rothmund-Thomson Syndrome (RTS) (16,17). RTS
patients display growth deﬁciency, photosensitivity
with poikilodermatous skin changes, early graying and
hair loss, juvenile cataracts and osteogenic sarcomas.
RECQ4 mutations can also lead to RAPADILINO
syndrome (18) or Baller-Gerold syndrome (19).
Mutations in the two other human RecQ helicases,
RECQ1 and RECQ5, have not yet been genetically
linked to a disease; however, studies of mouse model
systems (Table 1 and discussed later in the review) suggest
that mutations in these RecQ helicases may lead to a
hereditary chromosomal instability disorder or predispose
individuals to cancer.
Roles ofRecQ helicases in DNA repair
Recent studies show that RecQ helicases interact
with DNA repair proteins and participate in several
DNA repair pathways. This is consistent with the
observation that RecQ helicases demonstrate structure-
speciﬁc DNA binding and have higher aﬃnity for DNA
structures that resemble DNA repair intermediates
than for simple duplex DNA. A number of recent reviews
have summarized the evidence for RecQ helicases in
pathways that regulate genetic recombination and DNA
repair (3,12,14,20). In this review we will highlight
specialized roles of human RecQ helicases, particularly
the WRN and BLM helicases, in pathways necessary
for genomic stability and the prevention of human
diseases associated with premature aging and cancer.
Cellular functions ofRecQ helicases mediated by
their catalytic activities and proteininteractions
The deﬁciencies in replication and DNA repair character-
istics of RecQ mutant cells suggest direct roles of
the corresponding RecQ helicases in these processes.
A number of biochemical studies from diﬀerent labs
have contributed to our understanding of the structural
and catalytic properties of RecQ helicases. The ability of a
large number of RecQ helicases to act upon key DNA
replicational and repair intermediates (Figures 2A–I)
suggest that these enzymes represent a novel class of
proteins to facilitate DNA metabolic functions such as
replication restart, recombinational repair and other
DNA repair processes such as BER or DSBR. In addition
to their catalytic properties, RecQ helicases interact with a
number of key protein partners (Table 2) that are
implicated in genome stability maintenance through their
replication and repair functions. In the following sections,
we will highlight what we believe to be some of the most
important RecQ functions in terms of the cellular roles of
RecQ helicases in DNA metabolism.
The single-stranded DNA bindingprotein Replication
proteinA isan importantprotein partner forhuman RecQ
helicases inthe DNA unwinding reaction
A key property of DNA helicases is their ability to
unwind long duplexes. Certain DNA helicases (e.g.
RecBCD (21) and TraI (22)) can processively unwind
DNA tracts of thousands of base pairs, whereas UvrD
helicase only unwinds long DNA duplexes in a protein
concentration-dependent manner (23). In contrast, the
human RecQ helicases, WRN and BLM, are compro-
mised in their ability to unwind duplexes and can
only unwind DNA substrates of 100bp or less in the
absence of an auxiliary factor (24). Real-time pre-steady
state kinetic studies demonstrate that the WRN helicase
unwinds short (19bp) duplex DNA as a monomer (25);
however, the active functional state of unwinding for
a number of RecQ helicases remains debatable (14). RecQ
helicases such as WRN and BLM may be speciﬁcally
tailored to act upon short duplex substrates that
they encounter during a process associated with DNA
repair or replication restart (Figure 2). Alternatively, the
RecQ helicase could be associated with another DNA
replication/repair protein that serves as an accessory
factor, such as Replication protein A (RPA), to facilitate
unwinding of longer DNA duplexes that is required
during the cellular DNA metabolic processing events.
These two possibilities are not mutually exclusive.
Given the potential involvement of RecQ helicases in
DNA replication, repair and recombination, it will be of
interest to determine the role(s) and DNA unwinding
mode(s) of these helicases in diﬀerent sub-complexes.
Table 1. RecQ syndromes and mouse models
RecQ Helicase Human Mouse
Symptom Cellular phenotype Symptom Cellular phenotype
WRN Premature aging Genomic instability None detected None detected
WRN
 /  tert
 /  – – Premature aging Telomere dysfunction
BLM Increased cancer Elevated SCE Null, embryonic lethal
hypomorphic, increased
cancer after 1 year
Elevated SCE, elevated
MR, LOH
BLM
 /  tert
 /  – – Tert
 /  pathology Telomere dysfunction
RECQ4 Premature aging Genomic instability Growth retardation, skin
abnormalities
Sister chromatid, cohesion defect
RECQ5 ? ? None detected Elevated SCE
RECQ1 (RECQL) ? ? None detected Genomic instability, elevated SCE
Note: SCE, sister chromatid exchange; MR, mitotic recombination; LOH, loss of heterozygosity.
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Table 2. Highly signiﬁcant human RecQ protein interactions
RecQ helicase Interacting Partner Biochemical and/or biological function Reference
WRN RPA Stimulate WRN helicase, DNA damage response 24,26,27,31
FEN-1 Stimulate FEN-1 nuclease, processing of replication
fork and repair structures
66,67,69–71
PARP Inhibit WRN helicase and exonuclease, BER 76–78
Ku70/80 Stimulate WRN exonuclease, NHEJ 97,98
TRF2 / POT1 Stimulate WRN helicase, telomere function 126,127,136,137
Pol d Stimulate pol d DNA synthesis, replication 93,94
Rad52 Inhibits or stimulates WRN helicase in DNA
structure-speciﬁc manner, HR
84
p53 Inhibits WRN catalytic activities, apoptosis 38–41
MRE11-RAD50-NBS1 Promotes WRN helicase activity, HR repair 85
BLM RPA Stimulate BLM helicase, DNA damage response 24, 28
FEN-1 Stimulate FEN-1 nuclease, processing of replication
fork and repair structures
68, 69, 71
Top3a/BLAP75(RMI1) Double HJ dissolution, resolve recombination/late
stage replication structure
48–52
CAF-1 Inhibit CAF-1 mediated chromatin assembly during DNA repair 36
RECQ1 RPA Stimulate RECQ1 helicase 29
EXO-1 Stimulate EXO-1 nuclease 173
RECQ5b RPA Stimulate RECQ5b helicase 30
RECQ4 Rad51 Co-localize upon DSB induction 82
Note: For WRN and BLM, emphasis is placed on protein interactions in which cellular studies implicate biological importance. Additional protein
interactions for WRN and BLM have been reported.
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an auxiliary factor such as RPA may serve to regulate
DNA metabolic processes fundamental to replication
restart or recombinational repair and/or prevent unneces-
sary formation of single-stranded DNA that may be
deleterious for genomic stability.
The functional interaction and mechanism whereby
RPA stimulates the DNA unwinding reactions catalyzed
by human RecQ helicases is speciﬁc as evidenced by
the inability of heterologous, single-stranded DNA
binding proteins such as E. coli single-stranded DNA
binding protein (ESSB) or T4 Gene 32 to enhance
unwinding of long (several hundred bp) DNA substrates
by human RecQ helicases [for review, see (14)].
The speciﬁcity of the RPA interaction was observed for
the human RecQ helicases, WRN (26,27), BLM (28),
RECQ1 (29) and RECQ5b (30) (Table 2), suggesting
a similar mechanism for stimulation. The physical
interaction between RPA and human RecQ helicases
(WRN and BLM) was shown to play an important role
in the mechanism for RPA stimulation of helicase-
catalyzed DNA unwinding (24). However, WRN and
BLM interact with RPA70 via domains of the helicase
that are functionally conserved but do not display
extensive sequence homology (24). The interaction of
RPA with its partner helicase is likely to be complex.
For example, the WRN interacting domain and ssDNA
binding domain of RPA overlap with each other (24,31),
suggesting that ssDNA and WRN protein-binding
domains of RPA70 are functionally intertwined.
In addition to RPA loading a DNA processing protein
such as helicase on to ssDNA, RPA interaction with
some helicases may enable them to actively place RPA on
ssDNA as it emerges from the helicase complex (32).
Protein partners of RPA, such as helicases, may trade
places on ssDNA by binding to RPA and mediate
conformational changes that alter the ssDNA binding
properties of RPA. The order for sequential loading of
the RecQ helicase and RPA to unwind a DNA inter-
mediate is particularly interesting and challenging to
decipher since the precise details for the cellular roles of
the human RecQ helicases remain to be deﬁned.
Understanding the biological importance of the inter-
action of RPA with various RecQ helicases may be
highly relevant to deciphering the DNA metabolic defects
in RecQ helicase disorders. The coordinate action of RPA
and a RecQ helicase such as WRN is likely to play a
role in the replicational stress response since the two
proteins are known to co-localize at blocked replication
forks (33) or sites of DNA damage (34). In addition, RPA
may enable the RecQ helicase to unwind past DNA-
blocking base lesions (35) (Figure 2A). RecQ helicases
may play a role in DNA damage signaling or in chromatin
assembly associated with DNA repair (36). RPA is
implicated in signaling at stalled replication forks
where the accumulated ssDNA is bound by RPA, creating
a signal for activation of the ataxia-telangiectasia and
rad3-related (ATR)-dependent checkpoint response (37).
It will be important to address the role of RecQ protein
interactions with DNA repair factors such as RPA
that modulates its catalytic (helicase) activity to
understand their roles in DNA repair or DNA damage
signaling. The ability of the tumor suppressor p53 to
modulate RPA-dependent or RPA-independent WRN
catalytic activities (38–40) suggests a functional relation-
ship of the proteins in a pathway such as p53-mediated
apoptosis (41).
Rolesof RecQ helicases tosuppress SCEs
From a historical perspective, the roles of RecQ helicases
to maintain genomic stability through their interactions
with cellular topoisomerases have been well documented.
In E. coli, the prototype and singular RecQ helicase
interacts with Topoisomerase III (Top3) to suppress
recombination of newly replicated and catenated daughter
DNA molecules before cell division (42,43). Biochemical
demonstration of a concerted action of E. coli RecQ and
Top3 to catalytically link and unlink covalently closed
circular DNA molecules suggests a mechanism whereby
inappropriately joined DNA molecules can be resolved
from one another. In Saccharomyces cerevisiae, sgs1
mutation is a slow growth suppressor of the top3
mutant (44). Sgs1 and Top3 genetically and physically
interact, suggesting a model in which together they
suppress cross-over products that form during Holliday
Junction (HJ) resolution of recombination intermediates
(44,45). In S. pombe, the sole RecQ helicase Rqh1
functions with Top3 after DNA replication during G2
to facilitate DNA repair (46). Double strand break (DSB)
formation and hyper-recombination at replication fork
barriers and defective chromosome segregation in the
absence of Rqh1 may be a consequence of the defective
RecQ-topoisomerase interaction (47).
The abundant evidence for a direct physical and
functional interaction of prokaryotic and lower eukaryotic
RecQ helicases with Top3 evoked an interest in the
functional importance of this protein interaction in human
RecQ mutant cells and disorders. A hallmark for the
chromosomal instability of BS is the abundance of
quadriradial homologous chromosomes in BS somatic
cells that may arise from elevated SCE (3). On average,
the number of SCEs from metaphase spreads of BS
ﬁbroblasts is increased 7-fold compared to normal
ﬁbroblasts. Thus, elevated SCEs are used for the clinical
diagnosis of BS. The dramatically increased SCE in BS
has sparked an interest in understanding the cellular
and molecular mechanism for the peculiar type of
chromosomal instability. The conserved interactions of
RecQ helicases with topoisomerases provided a frame-
work for investigating BLM protein interactions.
In human cells, the BLM helicase forms a protein complex
with Top3a in PML nuclear bodies of exponentially
growing cells (48–50). An N-terminal region of BLM
protein was necessary and suﬃcient to bind Top3a, but
was not suﬃcient to suppress SCEs in vivo (48). In vitro
studies have demonstrated functional interactions between
BLM and Top3a. BLM together with Top3a has
the ability to catalyze double HJ dissolution on model
DNA substrates in a reaction that requires BLM-mediated
ATP hydrolysis and the active-site tyrosine residue
of Top3a (51) (Figure 2G). This reaction gave rise
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from the hemicatenane model, and supports a proposed
role of BLM with Top3a as a suppressor of SCEs.
Other RecQ helicases (RECQ1, WRN and RECQ5b)
fail to substitute for BLM in the in vitro double HJ
dissolution reaction (52). However, a functional connec-
tion between the yeast RecQ helicase SGS1 and
hemicatenanes, including in telomere maintenance was
recently reported (53–55).
Despite the apparent unique in vitro requirement for
BLM helicase to perform double HJ dissolution with
Top3a, mounting evidence suggests that other RecQ
helicases function in non-redundant pathways to
suppress cross-overs during mitosis. In chicken DT40
cells, RECQ5
 /  BLM
 /  cells have a higher frequency
of SCE compared with BLM
 /  cells (56). Mouse
models also suggest roles of other RecQ helicases than
BLM in the maintenance of chromosomal stability
(Table 1). An independent role of RECQ5 in the
suppression of SCEs was demonstrated in embryonic
stem (ES) cells or diﬀerentiated ﬁbroblasts from
RECQ5-knockout mice (57). Likewise, elevated SCE in
ES cells from RECQL knockout mice was also reported
(58), indicating that the RECQ1 helicase is uniquely
important for chromosomal stability. It will be a high
priority to delineate the functions and pathways of the
mammalian RecQ helicases to suppress SCEs since these
events lead to mutagenesis and genomic instability that
contribute to carcinogenesis.
Proposed roles ofstrand annealingcatalyzed by
RecQhelicases incellular DNA metabolism
In addition to their helicase activity, the human RecQ
helicases RECQ5b, RECQ1, WRN, BLM and RECQ4,
as well as the dmRECQ5b (dm is Drosophila melanogaster)
eﬃciently catalyze strand annealing of complementary
ssDNA molecules [for review, see (14)]. Strand annealing
catalyzed by RecQ helicases does not require ATP or
free Mg
2+. Analyses of strand annealing utilizing
ATP-binding/hydrolysis mutants revealed that nucleotide
binding inhibits strand annealing catalyzed by either
RECQ1 (59) or RECQ5b (30). ATP binding induces a
conformational change in RECQ1 protein, which serves
as a molecular switch from a strand annealing to a DNA
unwinding mode (59). RECQ1 assumes diﬀerent
oligomeric forms to perform its helicase and strand-
annealing activities (60). Coordination between the strand
pairing and the DNA unwinding activities of WRN or
BLM enables these enzymes to catalyze strand exchange
between a partial duplex and a complementary third
strand. Mapping studies demonstrated that the C-terminal
region after the helicase domain of RECQ5b mediates
strand annealing (30). The BLM C-terminal region
(amino acids 1267–1417) adjacent to the helicase-related
C-terminal (HRDC) domain is important for BLM strand
annealing and DNA binding (61). These ﬁndings suggest
that the annealing function is dictated by the poorly
conserved C-terminal regions in these RecQ helicases.
An important question remains concerning the
biological importance of strand annealing catalyzed by
RecQ helicases. The antagonistic catalytic action of
strand annealing versus DNA unwinding suggests that
these RecQ functions are regulated to perform DNA
transactions in speciﬁc pathways or steps of a given
pathway. Conceivably, RecQ assembly state (as
suggested by the RECQ1 oligomeric studies) may inﬂu-
ence the enzyme’s ability to act upon certain DNA
structures. The implicated roles of RecQ helicases for
the proper response to replicational stress suggests
that this class of enzymes have direct roles in the
metabolism of DNA structures associated with a stalled
or altogether blocked replication fork (Figure 2A–C).
Conceivably, strand annealing by RecQ helicases may
be important for replication fork regression (formation of
a ‘chicken foot’ structure) at blocked DNA replication
forks. BLM helicase, but not E. coli RecQ, was shown
to promote regression of a model replication fork in vitro
(62). Some diﬀerences in substrate speciﬁcity or direct-
ionality of unwinding a synthetic replication fork
structure have been observed among the RecQ helicases
(63,64), suggesting that these enzymes may have specia-
lized unwinding functions tailored for speciﬁc DNA
metabolic intermediates. Both WRN and BLM (but not
other selected helicases including UvrD, Rep, PriA
and E. coli RecQ) can coordinate their unwinding and
pairing activities to regress a model replication fork
substrate.
In the model for fork regression, replication fork
uncoupling at a polymerase-blocking lesion in the
leading strand template enables the synthesis of an
Okazaki fragment past the DNA damage (Figure 2B).
This is followed by fork regression in which the nascent
leading and lagging strands are annealed and the
longer lagging strand becomes a template for leading
strand synthesis. The four-stranded HJ structure can be
branch-migrated past the lesion to enable replication
restart (Figure 2C). Therefore, DNA unwinding and
strand-annealing activities catalyzed by RecQ helicases
may be important for replication fork regression
(formation of a chicken foot structure at blocked DNA
replication forks) and restoration of the fork for the
restart of replication by a non-recombinogenic
mechanism.
In vitro studies suggest that certain RecQ helicases
are able to deal with alternative recombination structures
(Figure 2D–F). Coordination between the strand-pairing
and DNA unwinding activities of WRN or BLM readily
achieves strand exchange between a partial duplex and
a complementary third strand. A mechanism for the
disruption of recombination intermediates of Okazaki
fragment maturation by BLM was proposed (65). BLM
strand exchange has the ability to eﬃciently dissociate
invading ﬂaps such as those of a D-loop sub-structure
provided that the exchange step does not involve
annealing of RPA-coated strands. The BLM functions
may inhibit illegitimate recombination during Okazaki
fragment processing. WRN and BLM both have
the ability to stimulate Flap Endonuclease 1 (FEN-1)
structure-speciﬁc cleavage of ﬁxed (66–69) and equilibrat-
ing (70,71) ﬂap structures, the latter being a proposed
physiological substrate of FEN-1; however, the
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in this pathway remains to be shown. Thus, the ability of a
WRN C-terminal domain that lacks the nuclease or
helicase functions to rescue the replication defects of a
dna2 mutant may reﬂect its physical and functional
interaction with FEN-1 (71), its strand-annealing
activity if it is intrinsic to the C-terminal domain and
active in this fragment, or a combination of both FEN-1
protein interaction and strand annealing all mediated
by the WRN C-terminal domain. Alleles of WRN that
cause WS appear to be null (7), precluding the
identiﬁcation of a single protein domain important for
causing the disease symptoms.
Some insightas to how the coordinate functions of DNA
unwinding and strand annealing by the same protein are
important in a single pathway may be garnered from a
model proposed for the role of Drosophila BLM in the
synthesis-dependent strand annealing (SDSA) pathway
during DSBR (72,73). According to this model, repair
synthesis during SDSA is not processive, releasing the
newly synthesized strand to search for a complementary
sequence. In the absence of a complementary single strand,
the nascent strand is further extended by a subsequent
round of strand invasion and DNA synthesis. In vitro,
several human RecQ helicases have been shown to release
the invading third strand from D-loop structures (14),
suggesting that the enzyme may act to release the newly
synthesized strand from a RAD51-mediated D-loop
formed in vivo during recombination or processing of
replication intermediates. However, the ability of a RecQ
helicasetocatalyzeDNAstrandannealingcouldbeutilized
to anneal a newly synthesized strand to its complementary
strand as the ﬁnal step after repair synthesis. Unlike a HR
pathwaythatinvolvesHJresolutiontoproducecrossovers,
repairof DSBsbySDSA resultsin geneconversionwithout
crossing over to preserve genomic integrity.
Lastly, the coordinate action of DNA unwinding and
strand annealing catalyzed by a RecQ helicase could be
used for the branch migration activity on D-loop or HJ
structures during HR associated with DNA repair or
replication, as discussed above. Since branch migration
activity requires the simultaneous disruption and anneal-
ing of complementary DNA strands, a RecQ helicase
capable of catalyzing the dual activities may be well suited
to fulﬁll this role. As suggested earlier, such coordination
may help explain the ability of WRN (33) and BLM (74)
to catalyze branch migration unidirectionally through
long stretches of DNA.
Collaboration between RecQ helicases and PARP-1
Poly (ADP) ribose polymerase-1 (PARP-1) is a central
enzyme in the DNA damage signaling process (75). Upon
breaks in DNA the enzyme becomes auto-ribosylated
and PARP-1 subsequently ribosylates a large number
of other cellular proteins including histones. PARP-1
plays important roles in the cellular response
to DNA damage including the post-translational mod-
iﬁcation of DNA repair proteins involved in repair
pathways linked to the prevention of aging. Speciﬁcally,
PARP-1 plays a major role in the process of BER.
It is therefore of interest that PARP interacts with RecQ
helicases such as WRN. Through its physical interaction
with WRN, PARP-1 modulates WRN exonuclease
and helicase activities (76). Simultaneously, WRN func-
tion is required for PARP-1 ribosylation as this process
is signiﬁcantly diminished in WRN-deﬁcient cells (77).
Genetic cooperation between WRN and PARP-1 was
demonstrated in mice whereby WRN and PARP-1
collaborate to prevent chromatid breaks, complex chro-
mosomal rearrangements and cancer (78). There is also
evidence for interaction of other RecQ helicases with
PARP-1 as in the case of its association with RTS (79).
Interactions of RecQhelicases withHR proteins
RecQ helicases appear to exert a major function in
DSBR. This has been demonstrated in many ways and
at several levels. A number of examples of interactions
between the key recombination proteins and the RecQ
helicases exist (Table 2). Rad51 is a key player in the
strand invasion event of HR, and this protein associates
with WRN (80), BLM (81) and RTS (82). Rad51D
physically interacts with BLM and stimulates BLM
branch migration activity on HJ structures (83). Rad52
both inhibits and enhances WRN helicase activity in a
DNA structure-dependent manner, whereas WRN
increases the eﬃciency of Rad52-mediated strand
annealing (84), suggesting they may act together in
replication fork rescue after DNA damage. Rad54,
another key protein in this pathway, co-localizes strongly
with WRN, in particular after cellular stress (80).
Linkage of WRN with the Mre11-Rad50-NBS1 complex
via NBS1 (85) and the tumor suppressor BRCA1 (86)
have been established. The biochemical interactions are
supported by various genetic and cell biological observa-
tions demonstrating a central role for RecQ helicases
as regulators of genetic recombination at stalled replica-
tion forks or in DSBR through their interactions with
HR proteins.
WRNexonuclease and interactions withKucomplex
WRN is unique among the human RecQ helicases in
that the protein catalyzes 30 to 50 exonucleolytic digestion
of DNA (87–89). WRN exonuclease is stimulated by Zn
2+
(25), consistent with the metal-binding site in the
solved structure of a WRN exonuclease domain frag-
ment (90). WRN, like other proofreading nucleases
with which it shares homology (14), may remove a
mismatched nucleotide incorporated by a DNA polymer-
ase during DNA replication (88) or a DNA repair process
such as BER (91,92) (see Figures 2H–I). Interestingly,
although WRN interacts with human DNA polymerase d
(93) and stimulates the extension activity of yeast
DNA polymerase d (94) and human translesion DNA
polymerases (95), WRN increases the amount of errors
generated by PolZ (95). Also, WRN exonuclease is
blocked at certain lesions in DNA (96). Further work
is needed to sort out the details of WRN function at a
mismatch or related lesion in DNA.
WRN exonuclease activity is strongly stimulated by
the Ku heterodimer (97,98), a central player in the NHEJ
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WRN may be a partner in the end-joining process,
supported by the notion that both exonuclease and
helicase activities are required in this process. However,
Chen and coworkers reported that a WRN double mutant
that is inactive as a helicase and exonuclease complemen-
ted the NHEJ defect of WRN
 /  cells, suggesting a
structural role of WRN in optimizing this type of DNA
repair (100). WS cells do not show particularly strong
sensitivity to g-irradiation, which creates DSBs that are
removed by end joining. However, it is possible that WRN
is involved in this process at certain genomic sites or
regions rather than in the genome overall. One such region
might be the telomere, where WRN (101) and the Ku
heterodimer (99) are particularly prominent.
Evidence forarole of WRN helicase in BER
The molecular steps and the proteins involved in SP-BER,
LP-BER and ssDNA break repair (SSBR) are summarized
in Figure 3. Notably, WRN and BLM interact function-
ally with many proteins involved in BER and SSBR.
In particular, WRN interacts with apurinic/apyrimidinic
endonuclease (APE-1), the endonuclease that incises
abasic sites following lesion removal by upstream DNA
glycosylases. Recent studies show that APE-1 inhibits
WRN helicase (102). At the next steps in SP- and
LP-BER, WRN and BLM stimulate DNA polymerase
b, enhancing base incorporation (103). WRN (67) and
BLM (68) also strongly stimulate FEN-1, which cleaves
50 protruding ﬂaps generated by strand displacement
DNA synthesis during LP-BER. In vitro evidence also
indicates that WRN exonuclease acts as a proofreading
enzyme for DNA polymerase b during LP-BER (91,92).
Thus, these data indicate that WRN is an important
player in BER. Although WRN is not considered to be
an essential player in BER, an important role for WRN
in BER is supported by the ﬁnding that WRN-deﬁcient
cells accumulate 8-oxoG (104) and are sensitive to some
DNA damaging agents that are repaired by BER (91,105).
While WRN interacts functionally with DNA polymerase
ß and APE-1 endonuclease, it does not appear to interact
with the glycosylase associated with that pathway,
oxoguanine DNA glycosylase (OGG1). It does, however,
interact with another glycosylase, endonuclease VIII
(Nei)-like protein (NEIL1), which is stimulated by WRN
(106). NEIL1 recognizes FaPy lesions in DNA and is
involved in the SSBR pathway involving polynucleotide
kinase (PNK). Thus, WRN participates in more than
one SSBR pathway. WS cells also display a hyper-
oxidation phenotype (107) and rapid accumulation of
protein carbonyls (5), a protein modiﬁcation that is
known to accumulate in older normal individuals.
Maintenance of telomere stability by RecQ helicases
Telomeres are specialized nucleoprotein complexes that
reside at the physical ends of linear eukaryotic
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7534 Nucleic Acids Research, 2007, Vol. 35, No. 22chromosomes that exist in all vertebrates [for review, see
(108)]. In most organisms studied, telomeres contain
lengthy stretches of tandemly repeated simple DNA
sequences composed of a G-rich strand and a C-rich
strand (called ‘terminal repeats’). These terminal repeats
are highly conserved since all vertebrates appear to
have the same telomeric DNA repeat of (TTAGGG)n
which repeats for several kilo-bases. These tandem
repeats form a scaﬀold that many diﬀerent telomeric
proteins bind forming the DNA-protein complex (109).
Telomeric DNA has a variety of structures within it
[for review, see (110)]. The 30 single-stranded DNA tail is
thought to play an important role in the structure and
function of telomeres (111,112). In certain cells that
utilize an alternative lengthening of telomere (ALT)
pathway, the 30 end mediates the formation of large
loops where the presence of the 30 G strand overhang
at the end of the telomere is tucked back inside the
double-stranded DNA at the loop junction, forming a
structure referred to as the t-loop (113). The area where
the 30 G strand extension invades the duplex telomeric
repeats is called ‘D loop’ (displacement loop). Given the
fact that the 30 tail extension is G-rich, another structure
that may arise during telomere metabolism is the
tetraplex stabilized by planar arrays of four hydrogen-
bonded guanines (114). Evidence in support of this was
provided by the ﬁrst crystal structure of quadruplexes
formed from human telomere repeat sequences (115).
In vivo evidence for the existence of G-quadruplexes at
telomeres (116) and other regions of the genome (117)
was provided by cellular and molecular studies.
For further reading on the experimental evidence pertain-
ing to the existence and dynamic role of G4 DNA in living
cells, see (117).
The telomere caps function to protect the gene contain-
ing regions of the chromosome from events that may lead
to genome instability. In the absence of functional
telomeres, eukaryotic chromosomes become unstable
(118–120). The ends of the chromosomes may be mistaken
for DSBs by the DNA repair machinery. This may lead
to events that include degradation of the terminal region
of the chromosome, inappropriate recombination or
fusion of the ends of two chromosomes. All of these
processes would lead to abnormal chromosomes that
would break during mitosis, and result in severe damage
to the genome and the activation of DNA damage
checkpoints. Ultimately, this may give rise to activation
of apoptotic pathways or cellular senescence (121).
Telomere-speciﬁc proteins that are associated with the
human TTAGGG repeats at the ends of human chromo-
somes and protect chromosome ends are referred to
collectively as a protein complex called ‘shelterin’.
Currently, six shelterin subunits have been identiﬁed:
TRF1, TRF2, TIN2, Rap1, TPP1 and POT1. TRF1,
TRF2 and POT1 directly recognize and bind to the
TTAGGG repeats, and in conjunction with the TIN2,
Rap1 and TPP1 proteins form a protein complex that
distinguishes telomeres from other sites of DNA damage.
The shelterin complex protects telomeres by directly
aﬀecting the structure of telomeric DNA [for an in-depth
review, please see (122)]. In addition to the shelterin
proteins, a number of ‘tool-belt’ DNA processing factors
(Mre11/Rad50/Nbs1, ERCC1/XPF, DNA-PK, PARP-2,
Tankyrases and RAD51D) aﬀect telomere metabolism.
Together the shelterin and non-shelterin proteins have
important functions in the protection, replication and
stabilization of the chromosome ends. Several lines of
evidence have also implicated certain RecQ helicases in
telomere maintenance. The S. cerevisiae Sgs1 helicase
participates in a Rad52-dependent ALT pathway that
operates in telomerase negative mutants (123). Expression
of catalytically active human BLM helicase rescued
the telomere defects in telomerase-negative sgs1 (124),
suggesting that BLM and Sgs1 act catalytically upon
similar telomeric structures. BLM was observed to
promote telomeric DNA synthesis in ALT cells (125)
and interacts with the telomeric repeat-binding factors
TRF1 and TRF2 (126,127).
Molecular interactions of WRN protein with a number
of telosome proteins and telomeric DNA structures have
been reported (Table 3), and WRN helicase-nuclease is
implicated in telomere maintenance from a number of
biochemical and biological studies. Stochastic loss of
telomeres has been reported in cells deﬁcient for WRN
protein. WS ﬁbroblasts display defects associated with
telomere dysfunction, including accelerated telomere
erosion and premature senescence (128–130). The pre-
mature senescent phenotype of WS ﬁbroblasts can be
rescued by forced telomerase expression (131). Over-
expression of telomerase restores genomic stability to WS
ﬁbroblasts (132). Single telomere length analyses sug-
gested similar rates of telomere erosion in HPV E6-
expression clones of WS cells compared to normal cells;
however, in bulk cultures, even with single telomere
measurements, the rate of telomere shortening was
greater in WS cells (133). Expression of dominant-negative
WRN in a human tumor cell line expressing telomerase
resulted in an increased telomere loss and chromosome
function (134), suggesting a telomerase-independent func-
tion of WRN in telomere length maintenance that is
consistent with the role of Sgs1 in an ALT pathway for
telomere maintenance via HR.
Table 3. Molecular interactions of WRN with telosome proteins and
telomeric DNA structures
Direct WRN-interacting shelterin proteins
TRF1
TRF2
POT1
Ku 70/80
Telomere-interacting protein partners of WRN
ATM Rad51/Rad52
NBS1 RPA
BLM p53
PARP-1
WRN-interacting telomeric DNA structures
30 ssDNA overhang
T-loop
G4 tetraplex
Holliday junction
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has been proposed (135). Biochemical studies suggest
that WRN helicase collaborates with proteins of the
shelterin complex to facilitate telomere maintenance
(Table 3). For example, DNA unwinding catalyzed by
WRN (and BLM) helicases is stimulated by human TRF2
(125,127,136). WRN promotes unwinding of model
D-loop structures containing telomeric sequences
(Figure 2F) and is present at telomeres along with
other DNA repair proteins in cells that employ the ALT
pathway (101), suggesting a role of WRN helicase to
facilitate the ALT pathway. Interestingly, both catalytic
activities (helicase and exonuclease) of WRN are
involved in the resolution of a D-loop substrate (101)
(Figure 2F). WRN exonuclease needs to digest from the
30 end in order to decrease the duplex length, and thereby
allows WRN helicase to unwind the remaining duplex
region in the absence of RPA. The ability of WRN and
BLM helicases to unwind telomeric DNA structures is
stimulated by the telomeric SSB POT1 (protection of
telomeres-1) (137). Altogether, the results are consistent
with a model in which telomere-binding factors co-
operate with mammalian RecQ helicases in resolving
telomeric DNA structures in a manner that protects the
telomeric 30 tail as it is exposed during unwinding.
Furthermore, WRN is necessary for eﬃcient replication
of G-rich telomeric DNA, and defective telomere lagging
strand synthesis was reported in cells lacking WRN
helicase activity (138).
Curiously, a disease phenotype in WRN-deﬁcient
mice is absent (139) (Table 1). However, the long
telomeres of mice may have a protective eﬀect in WS
pathogenesis. In support of this idea, late-generation
telomerase and WRN-deﬁcient mice (mTerc
 /  WRN
 / )
with dysfunctional telomeres, generated independently
by two laboratories, display clinical symptoms resembling
WS (140,141). The mTerc
 /  WRN
 /  mice were char-
acterized by many of the clinical symptoms of premature
aging and the types of tumours (osteocarcinomas,
soft tissue sarcomas) typically observed in WS patients.
Cells from the mTerc
 /  WRN
 /  mice displayed
accelerated telomere shortening, chromosomal instability
and replicative senescence. The mTerc
 /  WRN
 /  cells
were also shown to have elevated recombination rates
between telomeres of sister chromatids (142). Restoration
of normal telomere SCE was dependent on WRN helicase
activity. The WRN-deﬁcient telomere dysfunctional
cells escaped senescence by the ALT pathway. These
ﬁndings suggest that the chromosomal instability and
cancer of WS is a consequence of aberrant telomere SCE
that activates the ALT pathway [for a review, see (143)].
Similar to mTerc
 /  WRN
 /  mice, the pathology
of later-generation mice with an mTerc
 /  allele combined
with a hypomorphic BLM
M3 allele showed an acceleration
of phenotypes characteristic of later-generation Terc
mutants (141) (Table 1). Pathologies not observed in
Terc mutants, such as bone loss observed in WS and BS,
were evident in mTerc
 /  double mutant backgrounds
with mutations in WRN or BLM. The phenotypes
associated with later-generation mice were more
severe in mTerc
 /  WRN
 /  BLM
 /  triple mutants
than the sum of these defects in each single mutant,
suggesting a synergistic interaction of WRN and
BLM helicases in telomere biology. Thus, the delayed
manifestation of the complex pleiotropic phenotypes
of WRN or BLM deﬁciency in mice may relate to telomere
shortening.
Resolution of alternate DNA structures by RecQ helicases
Motifs for the formation of G-quadruplex DNA struc-
tures are widely dispersed in eukaryotic genomes, and
can be found in telomeres, gene promoters elements
and recombination hotspots (144). Cellular pathways
including replication, recombination, transcription and
telomeric DNA elongation involve steps in which two
strands of duplex DNA can be unwound transiently,
providing an opportunity for the G-rich strand to form
quadruplex structures (145). Unregulated formation of
G4 DNA within chromosomal regions may potentially
lead to genomic instability or interfere with fundamental
processes of nucleic acid metabolism, including replication
or transcription.
RecQ family members are unusual in that they
preferentially unwind tetraplex DNA (Figure 2E)
and other alternate DNA structures (triplex DNA,
synthetic D-loops and HJs) compared to B-form DNA
(74,146–151). Both yeast Sgs1 helicase and its close human
homolog, BLM, unwind G4 DNA with at least 15-fold
preference relative to duplex substrates (148,150).
Furthermore, both BLM and Sgs1 preferentially unwind
G4 DNA relative to HJ substrates, reﬂecting an
increased G4 binding aﬃnity (152). The G4 binding
domain of BLM and E. coli RecQ was mapped to the
conserved RQC region of the proteins (153). G4 DNA
unwinding activity is proposed to contribute to the
function of Sgs1 in the maintenance of two G-rich
genomic domains, ribosomal DNA (154,155) and telo-
meres (156–158). A role of Sgs1 in ribosomal DNA
metabolism is suggested by the observations that
sgs1-deﬁcient strains are characterized by nucleolar
fragmentation (159,160). Like Sgs1, WRN is also
suspected to have a role in ribosomal DNA metabolism
based on the observation that a signiﬁcant fraction of
WRN is nucleolar (161). Based on in vivo evidence, it was
proposed that WRN helicase insures eﬃcient replication
of G-rich telomeric DNA, resulting in the proper
maintenance of telomeres and genomic stability (138).
G4 tetraplex resolution by WRN helicase was proposed to
be required for telomeric DNA replication since S-phase-
dependent telomere loss was detected in the absence of
WRN. Moreover, WRN depletion aﬀected replication of
the telomeric G-rich lagging strand template that is
proposed to form G4 structures (138). WRN helicase
facilitates yeast pol d synthesis through tetraplex and
hairpin structures (162), suggesting a role of WRN in
disruption of DNA roadblocks that impede replication
(Figure 2D–E). BLM and WRN helicases also resolve
triple helix structures that may interfere with replication
or transcription (146).
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In yeast there is only one RecQ helicase, Sgs1
(S. cerevisiae) or Rqh1 (S. pombe), whereas in humans,
there are ﬁve. It is of great interest to better understand
why so many RecQ helicases are required in humans
and how they interact or interplay in the diﬀerent
pathways in which they operate. How much redundancy
between the RecQ helicases exists? Can one RecQ helicase
take over for another? Studies addressing these
questions have been performed at various levels and in
diﬀerent biological systems. At the biochemical level,
there is evidence for a functional protein interaction
between WRN and BLM helicases (163), as BLM
inhibits WRN exonuclease. This is also supported by
observation of colocalization between these helicases, in
particular after cellular stress (163). As yet there is no
evidence for any synergistic function between these RecQ
helicases, but it seems a likely possibility, worthy of
future investigation, to determine whether there may be a
speciﬁc substrate, for example, a DNA modiﬁcation, on
which these helicases can together accomplish a function
that neither of them can do alone.
Functional roles of RECQ1 and RECQ5
RecQ helicases have multiple roles in DNA repair,
replication and recombination, S-phase checkpoint
and telomere maintenance; consequently, they are con-
sidered caretakers of the genome (14,164). Three of the
ﬁve human RecQ genes, designated BLM, WRN and
RECQ4, have been genetically linked to the autosomal
recessive diseases BS, WS and RTS, respectively, char-
acterized by a predisposition to cancer and chromosome
instability, but the clinical features and cellular pheno-
types are diﬀerent from each other, suggesting unique
roles of BLM, WRN and RECQ4 helicases as tumor
suppressors. For a recent review on the molecular genetics
of RECQ4, please see (165).
The biological signiﬁcance of the remaining two human
RecQ helicases, RECQ1 and RECQ5, is not yet known.
Very little is known about the cellular functions of
RECQ5 [for review, see (8)]; consequently, the focus
of this section of the review will primarily be on RECQ1.
The RECQ1 (RECQL) gene, originally cloned indepen-
dently by two groups (166,167), encodes the most
abundant of the ﬁve human RecQ helicases in resting B
cells, and its expression is upregulated in response to EBV
transformation or treatment with the tumor-promoting
agent, phorbol myristic acetate (168). Despite the fact
that RECQ1 was the ﬁrst human RecQ helicase protein
to be identiﬁed, little is known about its genetic functions
in mammalian cells. Studies utilizing chicken DT40
cells have shown that RECQ1 and RECQ5 have roles
in cell viability under a BLM-impaired condition, indicat-
ing a backup function for these helicases (56). However,
BLM, RECQ5 and RECQL have non-redundant roles
in suppressing crossovers in mouse ES cells and ﬁbro-
blasts (57,58) (Table 1), suggesting a cell type or species–
speciﬁc diﬀerence between the chicken and the mouse
systems.
RECQL-deﬁcient mice do not exhibit any apparent
phenotypic diﬀerences when compared to wild type
mice and appear to be normal and fertile, with normal
telomere lengths. Cytogenetic analyses of embryonic
ﬁbroblasts from the RECQL-deﬁcient mice revealed
aneuploidy, spontaneous chromosomal breakage and
frequent translocation events. RECQL-deﬁcient cells
were also hypersensitive to ionizing radiation and
exhibited an increased load of DNA damage, suggesting
that RECQL has a unique cellular role in DNA repair
required for genomic stability. Genetic background,
functional redundancy and perhaps other factors may
protect the unstressed mouse from the types of abnorm-
alities that might be expected from the severe chromoso-
mal aberrations detected at the cellular level. It is
conceivable that manifestation of cellular or organismal
phenotypes in Recql-null mice may be masked by other
genetic factors. For example, WRN-null mice do not
exhibit any phenotypes prevalent in WS; however,
premature aging phenotypes are observed in a WRN-
null telomerase-knockout mouse characterized by the
presence of critically short telomeres [for review, see
(135)]. Furthermore, late generation mTerc
 /  WRN
 / 
mouse embryonic ﬁbroblasts have an increased level
of DNA damage markers and replicative senescence,
properties similar to that observed in human WS
ﬁbroblasts.
Although a genetic disorder has not yet been linked to a
mutation in RECQ1, recent analyses of RECQ1 single
nucleotide polymorphisms have identiﬁed an association
of RECQ1 with a reduced survival of pancreatic cancer
patients (169,170). The chromosomal instability arising
from RECQ1 deﬁciency may contribute to a cancer
predisposition. Consistent with this notion, RECQ1 is
diﬀerentially upregulated in transformed cells or cells that
are actively proliferating (168).
Very recently, RECQ1 was identiﬁed as a member of a
piRNA protein complex that is important for gene
silencing (171). This is an unexpected and potentially
exciting role for RECQ1 protein in the metabolism of
regulatory small RNAs important for development
and mechanisms of inheritance. The mechanistic simila-
rities between piRNA synthesis and DNA replication
(172) suggest that RECQ1 and its associated DNA
replication/repair proteins [RPA (29), EXO-1 and
MSH2/6 (173)] may conceivably function together
involved in piRNA biogenesis. Further work is required
to understand RECQ1-piRNA genome defense associa-
tion. Presently, it can only be speculated if the piRNA
complex regulates the genome at the level of DNA or
histones, or at a post-transcriptional level. Interestingly,
QDE-3, the RECQ1 homolog in Neurospora crassa,
has also been implicated in gene silencing (174). The
qde-3 mutant was found to be hypersensitive to a variety
of DNA mutagens and exhibit increased mutability
and extensive chromosomal deletions (175–177), implicat-
ing a broader role of the Neurospora RECQ1 homolog
in the DNA damage response and chromosomal stability.
A high priority will be to deﬁne the mechanism(s) of
RECQ1 in its inter-connected roles in gene silencing
and chromosomal stability maintenance.
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havefunctional implications
There is a growing interest in the molecular and
biological consequences of post-translational modiﬁca-
tions of RecQ helicases. One of the well-characterized
protein modiﬁcations of a mammalian RecQ helicase
is WRN phosphorylation (12). WRN becomes phos-
phorylated after cellular exposure to the double-strand
breaking agent bleomycin or after replicational stress
(178–181). Protein kinases responsible for WRN phos-
phorylation are DNA-PKcs, ATM and c-Abl. WRN
phosphorylation by DNA-PK complex inhibits WRN
exonuclease and helicase activities and may be important
in the NHEJ pathway of DSBR (179). c-Abl phosphor-
ylation of WRN protein, also inﬂuenced by cellular
exposure to DNA damaging agents such as bleomycin,
inhibits WRN helicase and exonuclease activities as
well (178). The precise pathways of the DNA damage
response that are regulated by phosphorylation of WRN
and other RecQ helicases remain to be characterized.
BLM is likely phosphorylated by ATM in response to
ionizing radiation and ATR in response to DNA
replicational stress [for review, see (8)].
Other types of known WRN protein post-translational
modiﬁcations include acetylation and sumoylation. It
has been proposed that SUMO modiﬁcation of WRN is
important for sub-nuclear relocalization of WRN during
the DNA damage response (182,183). Intra-nuclear
traﬃcking of the BLM helicase to DNA damage-induced
foci is also regulated by SUMO modiﬁcation (184).
p300 acetylation of WRN also aﬀects its sub-nuclear
relocalization after DNA damage (185). Understanding
the consequences of protein post-translational modiﬁca-
tions for RecQ relocalization and function in the
response to blocked or damaged replication forks, DSBs
directly introduced by DNA damaging agents, and other
types of DNA base modiﬁcations will be important to
assemble regulatory pathway models that will hopefully
lead to greater insight of the deﬁciencies associated with
diseases of genomic instability, cancer and aging.
Therapeutic implications ofRecQ helicase research
RecQ helicase disorders provide provocative models
that are useful for studying human diseases of aging
and cancer. Although the RecQ helicase disorders
identiﬁed are relatively rare, the mutational status of
RecQ helicase genes may have pathological inﬂuences that
are yet to be fully appreciated. For example, the possibility
that heterozygous mutations in the WRN gene may
predispose individuals to age-associated symptoms has
attracted interest (7). An ongoing eﬀort has been the
molecular diagnosis of WS and clinical outcomes
[The International Registry of Werner syndrome
(www.wernersyndrome.org)] (9). Only a limited number
of WRN polymorphic variants existing in the normal
population that potentially aﬀect aging have been
studied (186,187). Clearly, much work is to be done to
identify and characterize polymorphisms in RecQ heli-
cases as risk factors for age-related diseases or cancer.
Several human RecQ helicases have been shown to
be upregulated in rapidly proliferating or transformed
cells (168). Because of their essential roles in DNA
metabolism, and more speciﬁcally the DNA damage
response, dysregulation of RecQ helicases may be a
central feature in aging and cancer, more speciﬁcally in
age-associated diseases. Thus treatment aﬀecting the
functions of RecQ helicases could be of great relevance
to cancer (188–190) and other diseases. Combinatorial
treatments have been proposed for combating cancer
by inhibiting RecQ helicase function in tumor cells that
already have compromised DNA repair and/or DNA
damage signaling. Of particular interest is the possibility
that DNA helicases such as WRN may be targeted to
impair DNA cross-link repair or DSBR since a number
of DNA chemotherapy strategies rely on radiation or
DNA damaging drugs that introduce interstrand cross-
links or double-strand breaks. The idea that WRN
helicase may be a suitable target for chemotherapy
treatments is supported by the observation that epigenetic
inactivation of the WRN gene by hypermethylation
in colorectal tumors served as a useful predictor of
robust clinical response to irinotecan, a topoisomerase
inhibitor used to clinically treat this tumor type (191).
The abundant evidence for the direct involvement of
RecQ helicases in either NHEJ or HR pathways of DSBR
provides a strong incentive to screen small molecule
libraries to identify inhibitors of DNA helicases such as
WRN or BLM. These compounds might be tested in
model systems for cytotoxicity in combination with
various DNA damaging agents, replication inhibitors or
radiation to identify viable combinatorial strategies.
Characterization of small molecule RecQ helicase inhibi-
tors in such model systems may lead to their implementa-
tion in preclinical and clinical studies.
As discussed above, the WRN and BLM helicases
eﬃciently resolve G4 tetraplex structures. A number of
DNA binding compounds that preferentially interact
with G4 DNA have been investigated as potential anti-
cancer drugs since G-rich DNA is found in telomeres,
gene promoter elements such as the c-MYC oncogene
and recombination hotspots (144). Notably, MYC stimu-
lates expression of the WRN gene and WRN upregulation
promotes MYC-driven tumorigenesis by preventing
cellular senescence (192,193). Inhibition of WRN or
BLM unwinding of tetraplex structures by small molecules
that stabilize G4 DNA may be used to regulate gene
expression of oncogenes or aﬀect telomere metabolism.
Malignant transformation is associated with the upregula-
tion of telomerase expression and telomerase activation
plays a role in tumor formation (194). As an alternative
to inhibition of telomerase expression or activity, G4
structures at telomeres may be stabilized by G4-interactive
small molecules that prevent access of telomerase to
the telomeric ssDNA. Inhibition of G4 resolving helicases
such as WRN or BLM may provide yet another strategy
to inhibit telomerase function by preventing access
of telomerase to the ssDNA template.
Although RecQ helicases represent a viable target
for anti-cancer therapy, potential obstacles include the
non-speciﬁc cytotoxicity of DNA damaging treatments
7538 Nucleic Acids Research, 2007, Vol. 35, No. 22with helicase inhibitors, therapy-related carcinogenesis
and the potential functional redundancy of DNA
damage response helicases. These topics are discussed in
(189). Despite these caveats, RecQ helicases are a unique
class of DNA repair proteins that may serve as viable
targets to chemosensitize cancer cells.
Perspectives
Understanding the mechanistic basis of human aging is
a formidable challenge. The connection of age-related
diseases and cancer to mutations in genes that control
chromosomal stability provide an opportunity to study
genetic, molecular, cellular and ultimately organismal
aspects of the aging process. In this regard, study of the
RecQ family of DNA helicases has provided new
insights into the critical importance of genome integrity
and DNA repair for genome homeostasis and the
prevention of cellular decline in function. The importance
of RecQ helicases is emphasized by their direct roles
as guardians of the genome. An even more in-depth
understanding of the mechanisms of RecQ helicases in
pathways of DNA metabolism and maintenance of
genomic stability during the next decade will surely lead
to new advances in aging and cancer research since
the cloning of the ﬁrst human RecQ helicase genes WRN
and BLM, a little over a decade ago. Excitement abounds
in the RecQ helicase ﬁeld for the discoveries which
lie ahead that may lead to better diagnosis, treatment,
and understanding of cancer and aging.
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